Porcine Vaccine Global Market Report 2025

Global Porcine Vaccine Market Report 2024

Porcine Vaccine Global Market Report 2025 – By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines), By Disease Indication (Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications), By End User (Veterinary Hospitals, Hog or Pig Production Farm) – Market Size, Trends, And Global Forecast 2025-2034

Name: Porcine Vaccine Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Porcine Vaccine Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Porcine Vaccine Global Market Report 2025

Proud Members Of

Porcine Vaccine Market Definition

Porcine vaccines are a medical and pharmaceutical treatment that improves the health of pigs by shielding them from different bacteria, viruses, and other infections. It is used to increase the efficacy of protecting pigs from harmful ailments while increasing the output of top-notch meat for human consumption.

The major technologies used in porcine vaccines are inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. An inactivated vaccine is a type of vaccine made from a virus or bacterium that has been killed or inactivated, meaning IT is no longer capable of replicating or causing disease. Inactivated porcine vaccines stimulate an immune response to protect the pigs against later natural infection with the organism from which the vaccine was administered. It is used in various disease such as diarrhea, swine influenza, Arthritis, bordatella rhinitis, porcine reproductive and respiratory virus (PRRSV), porcine circovirus-associated disease (PCVAD) and others, that are used in hospitals and hog or pig production farm.

Porcine Vaccine Market Segmentation

The porcine vaccine market covered in this report is segmented –

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

3) By End User: Veterinary Hospitals, Hog or Pig Production Farm

Subsegments:

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines

3) By Toxoid Vaccines: Inactivated Toxins

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines

6) By DNA Vaccines: Plasmid DNA Vaccines

Porcine Vaccine Market Size and growth rate 2025 to 2029: Graph

Porcine Vaccine Market Size 2025 And Growth Rate

The porcine vaccine market size has grown strongly in recent years. It will grow from $1.89 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to disease outbreaks and control measures, global increase in pork consumption, intensification of pig farming, government initiatives for disease control, awareness and education programs.

Porcine Vaccine Market Growth Forecast

The porcine vaccine market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to global expansion of pig farming, rising disease challenges, stringent regulations and compliance, technological advancements in vaccine development, global trade and disease risk mitigation. Major trends in the forecast period include customization of vaccines for regional challenges, integration of biotechnology in vaccine development, rising concerns about zoonotic diseases, application of genomic approaches in vaccine design, growing investments in research and development.

Book your 30 minutes free consultation with our research experts

Porcine Vaccine Market Driver: Surging Swine Disease Infections Fuel Growth In Porcine Vaccine Market

The increasing infection of swine disease will propel the growth of the porcine vaccine market going forward. Swine influenza (swine flu) is a respiratory illness that affects pigs commonly caused by the type A influenza virus, which frequently causes influenza outbreaks in pigs. Porcine vaccines are instilled into pigs, where the pigs' immune systems react to the vaccine and recall the pathogenic agent by inducing an immunogenic reaction. These vaccines prepare the swine’s immune system to fight against pathogens and prevent the sickness by exerting an anamnestic reaction when encountering the same pathogen. For instance, in September 2024, according to the Government of the United Kingdom, a UK-based information website, an outbreak of African swine fever (ASF) could severely affect the UK's £8 billion pig industry, as well as its £600 million annual exports of pork and pork products. The estimated financial impact of such an outbreak could range from £10 million to £100 million. Therefore, the rising infection of swine disease is driving the porcine vaccine market.

Porcine Vaccine Market Driver: Rising Pork Consumption Fuels Growth In The Porcine Vaccine Market

The increasing pork consumption is expected to propel the growth of the porcine vaccine market going forward. Pork consumption is the quantity of pork meat that people or groups eat in a specific amount of time. The consumption of pork has increased in tandem with the growing global population and the growing demand for protein. Because of this trend, pig farming has to become more efficient, and vaccinations are essential to keeping pig herds healthy and productive. For instance, in March 2022, according to the report of Pig333, a Spain-based company that focuses on the pig industry, pork consumption in China was about 61, 52, and 37 kg/inhabitant. By 2022, consumption in China is expected to grow by 4.1%, reaching almost 52 kg/inhabitant. Therefore, increasing pork consumption is driving the growth of the porcine vaccine market.

Global Porcine Vaccine Market Major Players

Major companies operating in the porcine vaccine market include Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH

Global Porcine Vaccine Market Trend: Strategic Partnerships In The Porcine Vaccine Market Pirbright And TVG Collaborate To Develop Innovative African Swine Fever Vaccines

Major companies operating in the porcine vaccine market are adapting strategic partnerships to enhance their research and development capabilities and strengthen their competitive position in the rapidly evolving animal health industry. The collaboration makes use of TVG's experience in vaccine technology and Pirbright's expertise in African swine fever (ASF) research. The goal of this partnership is to improve the vaccine development process and develop novel approaches that have the potential to greatly improve swine health. For instance, in May 2024, The Pirbright Institute, a UK-based research institute, partnered with The Vaccine Group (TVG), a UK-based company, to develop a vaccine for African swine fever (ASF), The research aims to develop vaccines to prevent African swine fever (ASF) by using bovine herpesvirus 4 (BoHV-4) as a foundation. This method takes advantage of the latest breakthroughs in ASF vaccine research and pig immunology to design more efficient vaccines. The initiative is funded by the U.K.'s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).

Global Porcine Vaccine Market Trend: Innovative Advancements In Porcine Vaccines With 3-In-One Swine Vaccine For Enhanced Disease Protection

Major companies operating in the porcine vaccine market are developing innovative products, such as the 3-in-one swine vaccine, to provide better protection from various diseases. Swine vaccines are a crucial component of swine health management, aimed at protecting pigs from various diseases. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company dedicated to preserving and improving the health, well-being, and performance of animals through science, launched Circumvent CML, a three-in-one vaccine that controls for the diseases Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2D (PCV-2D), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. The innovative product gives producers and caregivers piece of mind by providing more convenience and further assurance that supplies are delivered appropriately. Merck's foundation of well-proven adjuvant systems and tried-and-true antigens serves as the basis for this novel vaccine. Circumvent CML reduces the number of injections for younger pigs and simplifies the vaccination process.

Porcine Vaccine Market Merger And Acquisition: Merck Animal Health Acquires Elanco Expanding Portfolio In Porcine Vaccines

In July 2024, Merck Animal Health Inc., a US-based company, acquired Elanco for an undisclosed amount. With this acquisition, Merck Animal Health aims to expand its portfolio by incorporating Elanco's expertise in providing porcine vaccines. Elanco Animal Health Inc, is a US-based company that offers porcine vaccines.

Regional Outlook For The Global Porcine Vaccine Market

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the porcine vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Porcine Vaccine Market?

The porcine vaccines market consists of sales of antibacterial vaccines and antiviral vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Porcine Vaccine Industry?

The porcine vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine vaccines market statistics, including porcine vaccines industry global market size, regional shares, competitors with a porcine vaccines market share, detailed porcine vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the porcine vaccines industry. This porcine vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Porcine Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.06 billion
Revenue Forecast In 2034	$2.96 billion
Growth Rate	CAGR of 9.5% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines 2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications 3) By End User: Veterinary Hospitals, Hog or Pig Production Farm Subsegments: 1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines 2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines 3) By Toxoid Vaccines: Inactivated Toxins 4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines 5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines 6) By DNA Vaccines: Plasmid DNA Vaccines
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Porcine Vaccine Market Characteristics

3. Porcine Vaccine Market Trends And Strategies

4. Porcine Vaccine Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Porcine Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Porcine Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Porcine Vaccine Market Growth Rate Analysis

5.4. Global Porcine Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Porcine Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Porcine Vaccine Total Addressable Market (TAM)

6. Porcine Vaccine Market Segmentation

6.1. Global Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Vaccines

Live Attenuated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Conjugate Vaccines

DNA Vaccines

6.2. Global Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diarrhea

Swine Influenza

Arthritis

Bordetella Rhinitis

Porcine Reproductive and Respiratory Virus (PRRSV)

Porcine Circovirus Associated Disease (PCVAD)

Other Disease Indications

6.3. Global Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Veterinary Hospitals

Hog or Pig Production Farm

6.4. Global Porcine Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Virus Inactivated Vaccines

Subunit Inactivated Vaccines

6.5. Global Porcine Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Modified Vaccines

Live Virulent Vaccines

6.6. Global Porcine Vaccine Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Toxins

6.7. Global Porcine Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Vector Vaccines

Subunit Recombinant Vaccines

6.8. Global Porcine Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polysaccharide Conjugate Vaccines

6.9. Global Porcine Vaccine Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plasmid DNA Vaccines

7. Porcine Vaccine Market Regional And Country Analysis

7.1. Global Porcine Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Porcine Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Porcine Vaccine Market

8.1. Asia-Pacific Porcine Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Porcine Vaccine Market

9.1. China Porcine Vaccine Market Overview

9.2. China Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Porcine Vaccine Market

10.1. India Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Porcine Vaccine Market

11.1. Japan Porcine Vaccine Market Overview

11.2. Japan Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Porcine Vaccine Market

12.1. Australia Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Porcine Vaccine Market

13.1. Indonesia Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Porcine Vaccine Market

14.1. South Korea Porcine Vaccine Market Overview

14.2. South Korea Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Porcine Vaccine Market

15.1. Western Europe Porcine Vaccine Market Overview

15.2. Western Europe Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Porcine Vaccine Market

16.1. UK Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Porcine Vaccine Market

17.1. Germany Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Porcine Vaccine Market

18.1. France Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Porcine Vaccine Market

19.1. Italy Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Porcine Vaccine Market

20.1. Spain Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Porcine Vaccine Market

21.1. Eastern Europe Porcine Vaccine Market Overview

21.2. Eastern Europe Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Porcine Vaccine Market

22.1. Russia Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Porcine Vaccine Market

23.1. North America Porcine Vaccine Market Overview

23.2. North America Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Porcine Vaccine Market

24.1. USA Porcine Vaccine Market Overview

24.2. USA Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Porcine Vaccine Market

25.1. Canada Porcine Vaccine Market Overview

25.2. Canada Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Porcine Vaccine Market

26.1. South America Porcine Vaccine Market Overview

26.2. South America Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Porcine Vaccine Market

27.1. Brazil Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Porcine Vaccine Market

28.1. Middle East Porcine Vaccine Market Overview

28.2. Middle East Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Porcine Vaccine Market

29.1. Africa Porcine Vaccine Market Overview

29.2. Africa Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Porcine Vaccine Market Competitive Landscape And Company Profiles

30.1. Porcine Vaccine Market Competitive Landscape

30.2. Porcine Vaccine Market Company Profiles

30.2.1. Sanofi Pasteur Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Arko Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Porcine Vaccine Market Other Major And Innovative Companies

31.1. Elanco Animal Health Incorporated

31.2. Ceva Santé Animale

31.3. Huvepharma Inc.

31.4. Phibro Animal Health Corporation

31.5. Vetoquinol SA

31.6. Intervet Inc.

31.7. HIPRA S.A.

31.8. Ringpu Bio-Pharmacy Co Ltd.

31.9. IDT Biologika GmbH

31.10. Bimeda Holdings PLC

31.11. Jinyu Bio-Technology Co Ltd.

31.12. Biogénesis Bagó

31.13. Pharmaq AS

31.14. Veterquimica S.A.

31.15. Kyoto Biken Laboratories Inc.

32. Global Porcine Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Porcine Vaccine Market

34. Recent Developments In The Porcine Vaccine Market

35. Porcine Vaccine Market High Potential Countries, Segments and Strategies

35.1 Porcine Vaccine Market In 2029 - Countries Offering Most New Opportunities

35.2 Porcine Vaccine Market In 2029 - Segments Offering Most New Opportunities

35.3 Porcine Vaccine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Porcine Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Porcine Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Porcine Vaccine Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Porcine Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Porcine Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Porcine Vaccine Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Porcine Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Porcine Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Sanofi Pasteur Inc. Financial Performance

Table 81: Boehringer Ingelheim International GmbH Financial Performance

Table 82: Zoetis Inc. Financial Performance

Table 83: Arko Laboratories Limited Financial Performance

Table 84: Merck Animal Health Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Porcine Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Porcine Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Porcine Vaccine Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Porcine Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Porcine Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Porcine Vaccine Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Porcine Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Porcine Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Sanofi Pasteur Inc. Financial Performance

Figure 81: Boehringer Ingelheim International GmbH Financial Performance

Figure 82: Zoetis Inc. Financial Performance

Figure 83: Arko Laboratories Limited Financial Performance

Figure 84: Merck Animal Health Financial Performance

The Hand-Held Chemical And Metal Detector Market Share, Market Size, And Growth Rate 2022

The Oleochemicals Market Share, Market Size, And Growth Rate 2022

Global Cattle Feed And Feed Additives Market 2022 – Market Opportunities And Strategies

Latest Equine Healthcare Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the companion animal veterinary vaccines market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the veterinary vaccines market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the veterinary pharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the veterinary parasiticides market research report 2022 with industry size, share, segments and market growth

Veterinary Infectious Disease Diagnostics Global Market Report 2025 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing animals), By Technology (Immunodiagnostics, Molecular Diagnostic, Other Technologies), By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Point of Care, Research Institutes and Universities, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Animal Antibiotics and Antimicrobials Global Market Report 2025 – By Type of Product (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Antimicrobials and Antibiotics), By Mode of Delivery (Premixes, Oral Powder, Oral Solution, Injection, Other Modes of Delivery), By Animal Type (Food-Producing Animals, Companion Animals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Antibiotics Global Market Report 2025 – By Product (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others), By End User (Farm Animals , Companion Animals), By Administration (Premixes, Injections, Oral Powders, Oral Solutions, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Pain Management Global Market Report 2025 – By Product (Drugs, Devices), By Animal Type (Companion Animals, Livestock), By Distribution Channel (Hospitals and Clinics, Pharmacy), By Application (Joint Pain, Postoperative Pain, Cancer, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Pharmaceuticals Global Market Report 2025 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines), By Route Of Administration (Oral, Parenteral, Topical, Other Routes Of Administration), By End User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Vaccines Global Market Report 2025 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Probiotics In Animal Feed Global Market Report 2025 – By Form Type (Dry, Liquid), By Source Type (Bacteria, Yeast and Fungi), By Application Type (Cattle, Poultry, Swine, Aquaculture, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Healthcare Global Market Report 2025 – By Type (Veterinary Services, Veterinary Medical Equipment, Animal Medicine), By Product (Instruments/Equipment, Disposables), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Other Animals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Porcine Vaccine market?

How will the Porcine Vaccine market drivers and restraints affect the market dynamics? What forces will shape the Porcine Vaccine industry going forward?

The Porcine Vaccine market major growth driver - Surging Swine Disease Infections Fuel Growth In Porcine Vaccine Market. For further insights on the Porcine Vaccine market, request a sample here

What is the forecast market size or the forecast market value of the Porcine Vaccine market?

The Porcine Vaccine market size has grown strongly in recent years. The porcine vaccine market size has grown strongly in recent years. It will grow from $1.89 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to disease outbreaks and control measures, global increase in pork consumption, intensification of pig farming, government initiatives for disease control, awareness and education programs. The porcine vaccine market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to global expansion of pig farming, rising disease challenges, stringent regulations and compliance, technological advancements in vaccine development, global trade and disease risk mitigation. Major trends in the forecast period include customization of vaccines for regional challenges, integration of biotechnology in vaccine development, rising concerns about zoonotic diseases, application of genomic approaches in vaccine design, growing investments in research and development. For further insights on the Porcine Vaccine market, request a sample here

How is the Porcine Vaccine market segmented?

The porcine vaccine market covered in this report is segmented –
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog or Pig Production Farm Subsegments:
1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines
2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines
3) By Toxoid Vaccines: Inactivated Toxins
4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines
5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines
6) By DNA Vaccines: Plasmid DNA Vaccines For further insights on the Porcine Vaccine market, request a sample here

Which region has the largest share of the Porcine Vaccine market? What are the other regions covered in the report?

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Porcine Vaccine market, request a sample here.

Who are the major players in the Porcine Vaccine market?

What are the key trends in the Porcine Vaccine market?

Major trends in the Porcine Vaccine market include Strategic Partnerships In The Porcine Vaccine Market Pirbright And TVG Collaborate To Develop Innovative African Swine Fever Vaccines. For further insights on the Porcine Vaccine market, request a sample here.

What are the major opportunities in the Porcine Vaccine market? What are the strategies for the Porcine Vaccine market?

For detailed insights on the major opportunities and strategies in the Porcine Vaccine market, request a sample here.

How does the Porcine Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Porcine Vaccine's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Porcine Vaccine industry?

For detailed insights on the mergers and acquisitions in the Porcine Vaccine industry, request a sample here.

What are the key dynamics influencing the Porcine Vaccine market growth? SWOT analysis of the Porcine Vaccine market.

For detailed insights on the key dynamics influencing the Porcine Vaccine market growth and SWOT analysis of the Porcine Vaccine industry, request a sample here.